| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abemaciclib in Combination With Pembrolizumab for Stage IV KRAS-Mutant or Squamous NSCLC: A Phase 1b Study
|
Pujol, Jean-Louis
|
|
|
|
11 |
p.
|
artikel
|
| 2 |
Acquired Hemophilia A Secondary to an Immune Checkpoint Inhibitor: A Case Report
|
Fletcher, James
|
|
|
|
11 |
p.
|
artikel
|
| 3 |
A Phase 1, Open-Label, Dose-Escalation Study of L-DOS47 in Combination With Pemetrexed Plus Carboplatin in Patients With Stage IV Recurrent or Metastatic Nonsquamous NSCLC
|
Piha-Paul, Sarina
|
|
|
|
11 |
p.
|
artikel
|
| 4 |
Author Reply: In Response to “De Novo KRAS G12C-Mutant SCLC: A Case Report”
|
Balbach, Meridith L.
|
|
|
|
11 |
p.
|
artikel
|
| 5 |
BMS-986012, an Anti–Fucosyl-GM1 Monoclonal Antibody as Monotherapy or in Combination With Nivolumab in Relapsed/Refractory SCLC: Results From a First-in-Human Phase 1/2 Study
|
Chu, Quincy
|
|
|
|
11 |
p.
|
artikel
|
| 6 |
Brief Report of Anti–Programmed Cell Death Protein-1 in Human Immunodeficiency Virus Setting: Relevant and Breaking Results in First-Line NSCLC Therapy
|
Bertin, Lise
|
|
|
|
11 |
p.
|
artikel
|
| 7 |
CADM1 and SPC25 Gene Mutations in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis
|
Fukuizumi, Aya
|
|
|
|
11 |
p.
|
artikel
|
| 8 |
Clinical Trial and Real-World Outcomes of Patients With Metastatic NSCLC in the Post-Platinum–Based Chemotherapy Failure Setting
|
Soon, Yu Yang
|
|
|
|
11 |
p.
|
artikel
|
| 9 |
Coexpression of ΔNp63/p40 and TTF1 Within Most of the Same Individual Cells Identifies Life-Threatening NSCLC Featuring Squamous and Glandular Biphenotypic Differentiation: Clinicopathologic Correlations
|
Pelosi, Giuseppe
|
|
|
|
11 |
p.
|
artikel
|
| 10 |
Conversion Surgery for Advanced Thoracic SMARCA4-Deficient Undifferentiated Tumor With Atezolizumab in Combination With Bevacizumab, Paclitaxel, and Carboplatin Treatment: A Case Report
|
Kunimasa, Kei
|
|
|
|
11 |
p.
|
artikel
|
| 11 |
Correspondence Regarding “Tolerability of Coronavirus Disease 2019 Vaccines BNT162b2 and mRNA-1273 in Patients With Thymic Epithelial Tumors”
|
Takada, Kazuki
|
|
|
|
11 |
p.
|
artikel
|
| 12 |
Development of Neuropathic Arthropathy With Entrectinib: Case Report
|
Giustini, Nicholas P.
|
|
|
|
11 |
p.
|
artikel
|
| 13 |
Effective Communication About Lung Cancer Screening Without Iatrogenic Stigma: A Brief Report Case Study Using the Lung Cancer Stigma Communications Assessment Tool of LungTalk
|
Carter-Bawa, Lisa
|
|
|
|
11 |
p.
|
artikel
|
| 14 |
Efficacy of Targeted Inhibitors in Metastatic Lung Squamous Cell Carcinoma With EGFR or ALK Alterations
|
Lewis, Whitney E.
|
|
|
|
11 |
p.
|
artikel
|
| 15 |
Frailty Is Associated With Adverse Postoperative Outcomes After Lung Cancer Resection
|
Lee, Andy Chao Hsuan
|
|
|
|
11 |
p.
|
artikel
|
| 16 |
Major Pathologic Response and Prognostic Score Predict Survival in Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy
|
Pataer, Apar
|
|
|
|
11 |
p.
|
artikel
|
| 17 |
Malignant Peritoneal Mesothelioma With EWSR1-ATF1 Fusion: A Case Report
|
Ke, Helen
|
|
|
|
11 |
p.
|
artikel
|
| 18 |
MET Amplification and Efficacy of Nivolumab in Patients With NSCLC
|
Yoshimura, Katsuhiro
|
|
|
|
11 |
p.
|
artikel
|
| 19 |
Osimertinib-Induced Cutaneous Vasculitis Responsive to Low-Dose Dapsone Without Interruption of Anticancer Therapy: A Case Report and Review of the Literature
|
Iriarte, Christopher
|
|
|
|
11 |
p.
|
artikel
|
| 20 |
Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC
|
Kim, Hye Ryun
|
|
|
|
11 |
p.
|
artikel
|
| 21 |
Pemetrexed and Platinum Plus Pembrolizumab in Patients With Metastatic Nonsquamous NSCLC by Tumor Burden at Baseline: A Post Hoc Efficacy Analysis of KEYNOTE-189
|
Gadgeel, Shirish
|
|
|
|
11 |
p.
|
artikel
|
| 22 |
Pneumonitis During Durvalumab Consolidation Therapy Affects Survival in Stage III NSCLC
|
Kinehara, Yuhei
|
|
|
|
11 |
p.
|
artikel
|
| 23 |
Potential Therapeutic Strategy for EGFR-Mutant Lung Cancer With Concomitant EML4-ALK Rearrangement—Combination of EGFR Tyrosine Kinase Inhibitors and ALK Inhibitors
|
Huang, Ming-Hung
|
|
|
|
11 |
p.
|
artikel
|
| 24 |
Predictive Impact of Diffuse Positivity for TTF-1 Expression in Patients Treated With Platinum-Doublet Chemotherapy Plus Immune Checkpoint Inhibitors for Advanced Nonsquamous NSCLC
|
Terashima, Yuto
|
|
|
|
11 |
p.
|
artikel
|
| 25 |
Programmed Death-Ligand 1 Expression in Lung Cancer and Paired Brain Metastases—a Single-Center Study in 190 Patients
|
Kündig, Alexandra
|
|
|
|
11 |
p.
|
artikel
|
| 26 |
Quality of Life After Stereotactic Body Radiation Therapy or Surgery for Early-Stage NSCLC: A Systematic Review
|
Iovoli, Austin J.
|
|
|
|
11 |
p.
|
artikel
|
| 27 |
Real-World Data Analysis of Pembrolizumab Monotherapy for NSCLC Using Japanese Postmarketing All-Case Surveillance Data
|
Terai, Hideki
|
|
|
|
11 |
p.
|
artikel
|
| 28 |
Real-World Evidence of EGFR Targeted Therapy in NSCLC– A Brief Report of Decade Long Single Center Experience
|
Chougule, Anuradha
|
|
|
|
11 |
p.
|
artikel
|
| 29 |
Repotrectinib Overcomes F2004V Resistance Mutation in ROS1-Rearranged NSCLC: A Case Report
|
Pizzutilo, Elio Gregory
|
|
|
|
11 |
p.
|
artikel
|
| 30 |
Severe Psychiatric Symptoms in a Patient With EGFR Exon-20 Insertion Mutation Receiving Mobocertinib: A Case Report
|
Kamel, Josette
|
|
|
|
11 |
p.
|
artikel
|
| 31 |
Successful Management of Generalized Myasthenia Gravis Induced by Atezolizumab in a Patient With Extensive-Stage SCLC: A Case Report
|
Wu, Shuang
|
|
|
|
11 |
p.
|
artikel
|
| 32 |
Surgical Insights Are Essential to Integration of Immune Therapy in Resectable NSCLC
|
Donington, Jessica S.
|
|
|
|
11 |
p.
|
artikel
|
| 33 |
Technical Feasibility and Safety of Repeated Computed Tomography–Guided Transthoracic Intratumoral Injection of Gene-Modified Cellular Immunotherapy in Metastatic NSCLC
|
Shahrouki, Puja
|
|
|
|
11 |
p.
|
artikel
|
Tijdschrift beschrijving